Patents
US 12247213 B2: Treatment of mucopolysaccharidosis IVA
- Granted
- 2025-03-11
- Filed
- 2019-07-26 application 17263049
- Type
- Utility · 16 claims
- Elsewhere
- Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗
Abstract
Provided herein are gene therapy methods for the treatment of mucopolysaccharidosis type IVA (MPS IVA) involving the use of recombinant adeno-associated viruses (rAAVs) to deliver human N-acetylgalactosamine-6-sulfate sulfatase (hGALNS) to the bone of a human subject diagnosed with MPS IVA. Also provided herein are rAAVs that can be used in the gene therapy methods and methods of making such rAAVs.
Source: PVGPATDIS, file of 2026-04-10 (ipg250311.xml).
Assignees
| Assignee | Type | Place | Also on furp.org | Source |
|---|---|---|---|---|
| The Nemours Foundation 18 patents | US company or organization | Wilmington, DE | THE NEMOURS FOUNDATION State business registration EXACT high confidence: identical full name and state THE NEMOURS FOUNDATION Nonprofit EXACT high confidence: identical full name and state | PVGPATDIS, file of 2026-04-10 |
| REGENXBIO INC. 15 patents | US company or organization | Rockville, MD | REGENXBIO Inc. Form D issuer EXACT high confidence: identical full name and state REGENXBIO INC. SEC filer EXACT medium confidence: identical full name, one of each nationally | PVGPATDIS, file of 2026-04-10 |
Inventors
| Inventor | Place | Patents | Person page | Source |
|---|---|---|---|---|
| Shunji Tomatsu | Wilmington, DE | 12 | PVGPATDIS, file of 2026-04-10 | |
| Kazuki Sawamoto | Tokyo, JP | 1 | PVGPATDIS, file of 2026-04-10 | |
| Subha Karumuthil-Melethil | Germantown, MD | 1 | PVGPATDIS, file of 2026-04-10 | |
| Olivier Danos | Princeton, NJ | 12 | PVGPATDIS, file of 2026-04-10 |
CPC categories
| Subclass | Category | First group | Source |
|---|---|---|---|
| C12N | Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media | C12N15/86 | PVGPATDIS, file of 2026-04-10 |
| A61K | Preparations for medical, dental or toiletry purposes | A61K48/0058 | PVGPATDIS, file of 2026-04-10 |
| A61P | Specific therapeutic activity of chemical compounds or medicinal preparations | A61P19/00 | PVGPATDIS, file of 2026-04-10 |
| A01K | Animal husbandry; aviculture; apiculture; pisciculture; fishing; rearing or breeding animals, not otherwise provided for; new breeds of animals | A01K2217/054 | PVGPATDIS, file of 2026-04-10 |
| C07K | Peptides | C07K2319/00 | PVGPATDIS, file of 2026-04-10 |
| C12Y | Enzymes | C12Y301/06004 | PVGPATDIS, file of 2026-04-10 |
Cooperative Patent Classification, as currently assigned (one row per subclass).
Assignments and security interests
| Recorded | What | From | To | Reel/frame | Source |
|---|---|---|---|---|---|
| 2021-09-21 | Assignment Assignment of assignor's interest | TOMATSU, SHUNJI signed 2021-04-20 SAWAMOTO, KAZUKI signed 2021-04-21 | THE NEMOURS FOUNDATION WILMINGTON, DE | 57541/837 | ECORSEXC, file of 2026-09-25 |
| 2021-04-20 | Assignment Assignment of assignor's interest | DANOS, OLIVIER signed 2021-03-17 KARUMUTHIL-MELETHIL, SUBHA signed 2021-03-29 | REGENXBIO INC. ROCKVILLE, MD | 55966/982 | ECORSEXC, file of 2026-09-25 |
Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.
USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.